The Therapeutic Benefits of LSD
Source: Dangerous Minds
For the first time in 40 years, scientists have carried out controlled medical experiments on the hallucinogenic drug LSD, and the results have been surprisingly positive.
The drug was used as part of a psychotherapy course to treat severe depression in terminally ill cancer patients.
In a pilot test, twelve men and women at a private practice in Solothurn, Switzerland, were given high doses of LSD. The results showed a 20 percent reduction in symptoms associated with extreme anxiety relating to their medical condition.
The test also revealed that lysergic acid diethylamide had no severe side effects.
However, it was found that when issued with low doses of LSD, the participants' depressive symptoms became worse.
The study, published in the Journal of Nervous and Medical Disease, concluded:
Psychiatrist Peter Gasser, who is based at the practice in Switzerland, said that eleven of the twelve participants involved in the trial had never taken LSD before, but all of them would take LSD again and would recommend the drug to other patients who were in a similar medical situation:
Gasser explained that eight of the trial were given a full dose of LSD, while four were given an "active placebo." The placebo group showed an increase in their anxiety symptoms associated with depressive illness. These four were subsequently given a high dose of LSD.
One participant described his experience as "mystical," and Dr. Gasser said all of the patients felt better in terms of their anxiety about being terminally ill. This improvement lasted for "at least twelve months after the therapy."
The last time medical trials used LSD on terminally ill patients was the early 1960s. LSD was made illegal in the United States in 1966.
Related Article: Top 10 Geniuses on Mind-Altering Drugs